LI
TMO icon

LMCG Investments’s Thermo Fisher Scientific TMO Stock Holding History

LMCG Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
2,287
+135
+6% +$64.8K 0.06% 165
2026
Q1 		$1.06M Buy
2,152
+47
+2% +$25.5K 0.06% 158
2025
Q4 		$1.22M Sell
2,105
-8
-0.4% -$4.52K 0.07% 147
2025
Q3 		$1.02M Sell
2,113
-766
-27% -$357K 0.06% 160
2025
Q2 		$1.17M Sell
2,879
-2,762
-49% -$1.15M 0.07% 156
2025
Q1 		$2.81M Sell
5,641
-87
-2% -$47.1K 0.19% 125
2024
Q4 		$2.98M Sell
5,728
-8,493
-60% -$4.67M 0.18% 123
2024
Q3 		$8.8M Sell
14,221
-161
-1% -$95.3K 0.53% 75
2024
Q2 		$7.95M Buy
14,382
+400
+3% +$229K 0.46% 79
2024
Q1 		$8.13M Sell
13,982
-198
-1% -$111K 0.48% 79
2023
Q4 		$7.53M Sell
14,180
-37
-0.3% -$17.9K 0.47% 77
2023
Q3 		$7.2M Sell
14,217
-351
-2% -$187K 0.49% 72
2023
Q2 		$7.6M Sell
14,568
-5,376
-27% -$2.9M 0.49% 73
2023
Q1 		$11.5M Sell
19,944
-151
-0.8% -$85.1K 0.77% 35
2022
Q4 		$11.1M Sell
20,095
-5
-0% -$2.65K 0.77% 34
2022
Q3 		$10.2M Sell
20,100
-9
-0% -$5.04K 0.75% 36
2022
Q2 		$10.9M Buy
20,109
+185
+0.9% +$102K 0.75% 34
2022
Q1 		$11.8M Buy
+19,924
New +$11.4M 0.68% 37

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LMCG Investments's TMO Position: Q2 2026 in Review

LMCG Investments increased its Thermo Fisher Scientific (TMO) stake by 6.3% in Q2 2026, buying an estimated $64.8K and bringing the position to 2,287 shares worth $1.15M. The position accounts for 0.06% of the portfolio, ranked #165.

LMCG Investments first reported a position in TMO in Q1 2022 and has held it in 18 quarters since. The position peaked at $11.8M in Q1 2022. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • LMCG Investments held 2,287 shares of Thermo Fisher Scientific worth $1.15M as of Q2 2026.
  • LMCG Investments bought 135 Thermo Fisher Scientific shares in Q2 2026, an estimated $64.8K.
  • Thermo Fisher Scientific made up 0.06% of LMCG Investments's portfolio in Q2 2026, its #165 holding.
  • LMCG Investments first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 18 quarters since.
  • LMCG Investments's Thermo Fisher Scientific position peaked at $11.8M in Q1 2022.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LMCG Investments's 13F filing for Q2 2026, filed 22 Jul 2026.